translate
Research News
IPF Research
Life with PF
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
PFF Educational Resources
PFF Educational Videos
Our Role
Who We Are
News & Media
Community Programs
Leadership
Financials
Contact Us
Career Opportunities
Get Involved
Attend an Event
Advocacy
Become a Sponsor
Broadway Belts for PFF
Plan a Fundraiser
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donate Now
Honor a Loved One
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Meet Sisi Suarez
Medical Community
COVID-19 Resources
Blog: PFF Insights
PFF Research Funds
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Patient Registry
Connect With Patients
CME/CE Library
Health Provider Resources
Sponsors and Exhibitors
Contact Us
join our
e
newsletter
|
translate
Join Our Monthly eNewsletter
Subscribe to receive the most current news and updates from the Pulmonary Fibrosis Foundation.
Life with PF
Education & Support
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Clinical Trials 101
PF Pipeline Glossary
Pipeline
Research News
IPF Research
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Ask A Doc March 2015
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
Our Role
Information & Programs
Who We Are
News & Media
News
Breathe Bulletin
Archive
Media Resources
PFF in the Media
Community Programs
PFF Care Center Network
PFF Patient Registry
PF Awareness Month
PFF Summit
PFF Patient Communication Center
PFF Oxygen Information Line
PFF Support Group Leader Network
PFF Ambassador Program
PFF Educational Videos
Leadership
Board of Directors
Stephen A. Wald
Stephen A. Wald
Joseph Borus
Stephen A. Wald
Medical Advisory Board
Research Review Committee
Medical and Scientific Advisory Committee
Financials
Contact Us
Career Opportunities
Get Involved
Events & Awareness
Attend an Event
Advocacy
Become a Sponsor
Broadway Belts for PFF
Plan a Fundraiser
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donations & Tributes
Donate Now
Honor a Loved One
Create or Donate to an Online Tribute/Memorial
Set Up Memorial Contributions
Celebrate Lifetime Events
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Meet Sisi Suarez
Medical Community
Research & Resources
COVID-19 Resources
Blog: PFF Insights
PFF Research Funds
I.M. Rosenzweig Junior Investigator Award
Albert Rose Established Investigator Award
PFF Scholars
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Patient Registry
Statements-HRCT
Statements-HRCT
Connect With Patients
Patient Education Materials
Host an Event
Support Groups
PFF Ambassador Program
CME/CE Library
Health Provider Resources
Stem Cell/Cell-Based Therapies for Pulmonary Fibrosis
Role of Surgical Lung Biopsy in ILD
HRCT Position Statement
Familial Pulmonary Fibrosis for Patients
Familial Pulmonary Fibrosis for Health Care Providers
Donate
Home
>
Life with PF
>
Clinical Trials Education Center
>
Pipeline
>
IPF Research
A
A
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Clinical Trials 101
PF Pipeline Glossary
Pipeline
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
IPF Research
See below for the latest in research news related to Idiopathic Pulmonary Fibrosis (IPF). This is where the PFF will share relevant news articles, press releases, and study results in the field of IPF.
First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis
by Kelsey Overberg
Jan 11, 2021
Full story
: First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
by Kelsey Overberg
Dec 29, 2020
Full story
: Phase 3 trial of Novavax investigational COVID-19 vaccine opens
FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
by Kelsey Overberg
Dec 21, 2020
Full story
: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
by Kelsey Overberg
Dec 18, 2020
Full story
: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
by Kelsey Overberg
Dec 18, 2020
Full story
: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
by Kelsey Overberg
Dec 18, 2020
Full story
: Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
by Kelsey Overberg
Dec 18, 2020
Full story
: AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
OncoImmune’s SACCOVID™ (CD24Fc) Exhibits Superb Therapeutic Efficacy—A Potential Breakthrough in Treating Severe and Critical COVID-19
by Kelsey Overberg
Dec 16, 2020
Full story
: OncoImmune’s SACCOVID™ (CD24Fc) Exhibits Superb Therapeutic Efficacy—A Potential Breakthrough in Treating Severe and Critical COVID-19
Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
by Kelsey Overberg
Dec 15, 2020
Full story
: Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
by Kelsey Overberg
Dec 15, 2020
Full story
: Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
by Kelsey Overberg
Dec 15, 2020
Full story
: FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
by Kelsey Overberg
Dec 11, 2020
Full story
: United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 Meeting
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
by Kelsey Overberg
Dec 11, 2020
Full story
: United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers
by Kelsey Overberg
Dec 8, 2020
Full story
: Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers
Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
by Kelsey Overberg
Dec 4, 2020
Full story
: Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse® for the Treatment of Fibrotic Interstitial Lung Disease
Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results
by Kelsey Overberg
Sep 23, 2020
Full story
: Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
by Kelsey Overberg
Sep 16, 2020
Full story
: Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
by Kelsey Overberg
Sep 15, 2020
Full story
: Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19
by Kelsey Overberg
Sep 15, 2020
Full story
: FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19
Pfizer and BioNTech share positive early data on lead mRNA vaccine candidate BNT162B2 against COVID-19
by Kelsey Overberg
Sep 15, 2020
Full story
: Pfizer and BioNTech share positive early data on lead mRNA vaccine candidate BNT162B2 against COVID-19
1
(current)
2
3
4
5